google_counter
background_img

University Hospital Muenster

location_on Muenster, Germany
9.8/10 from 78 Votes

Department of Nuclear Medicine (289952)

Michael Schäfers

Prof. Dr. med.

Michael Schäfers

Specialized in: nuclear medicine

About the department

The Department of Nuclear Medicine at the University Hospital Muenster offers all diagnostic and treatment options in the field of nuclear medicine at the highest medical and technical level. The Department specializes in the treatment of thyroid cancer and different oncological diseases. The Department is headed by Prof. Dr. med. Michael Schäfers.

Radioiodine therapy can be used for the treatment of various benign (Basedow’s disease, hyperthyroid goiter) and malignant (papillary and follicular thyroid cancer) thyroid tumors. The decision on the appropriateness of radioiodine therapy is usually made within the outpatient counseling in the unit for thyroid cancer at the University Hospital Muenster. All other necessary examinations can be provided in the Department during the consultation.  

The Department of Nuclear Medicine under the direction of Prof. Dr. med. Michael Schäfers at the University Hospital Muenster offers a wide range of treatments for tumors.

This includes the following options: 

  • Alpharadin treatment Indications: prostate cancer with bone metastases
  • Lutetium DODATE treatment Indications: neuroendocrine tumors
  • MIBG therapy Indications: neuroblastoma
  • PSMA therapy Indications: prostate cancer
  • Radioiodine therapy for malignant diseases of the thyroid gland – thyroid cancer Indications: papillary and follicular thyroid cancer
  • Samarium treatment Indications: analgesic therapy for bone metastases
  • SIR therapy Indications: liver metastases, liver cancer
  • Zevalin treatment Indications: non-Hodgkin’s lymphoma 

The diagnostic range of the Department of Nuclear Medicine at the University Hospital Muenster includes:  

  • Blood and lymphatic system
    • Gamma camera/ SPECT-CT
      • Blood volume
      • Red blood cells
      • Bone marrow
      • Lymphatic drainage for legs
      • Platelets
      • Sentinel lymph nodes (scintigraphy)
  • Brain
    • PET/CT
    • Amino acid metabolism (FET)
    • Beta-amyloids
    • Glucose metabolism (FDG)
    • SPECT-CT
      • Dopamine receptors (IBZM)
      • Dopamine transporters (DatSCAN®)
      • Perfusion
      • Liquor scintigraphy
  • Lungs
    • Pulmonary blood flow and ventilation
  • Heart
    • PET/CT
      • Glucose metabolism (FDG)
      • Innervation (HED)
      • Perfusion reserves (NH3)
  • SPECT/CT
    • Perfusion, myocardial scintigraphy
  • Gastrointestinal tract: Gamma camera / SPECT-CT
    • Source of the bleeding
    • Hepatobiliary function
    • Gastrointestinal tract
    • Meckel’s diverticulum
    • Esophagus
  • Kidneys: Gamma camera / SPECT-CT
    • Kidney function I (MAG3)
    • Kidney function II (DTPA)
    • Kidney function III (DMSA)
  • Thyroid and parathyroid gland
    • Fine needle aspiration of the thyroid 
    • Whole-body scintigraphy with iodine isotopes
    • Parathyroid scintigraphy
    • Thyroid sonography
    • Thyroid scintigraphy
  • Cancer and inflammation
    • PET-CT
      • Amino acid metabolism (FET)
      • Glucose metabolism (FDG)
      • Innervation (HED)
      • Bone metabolism (Fluorid)
      • Prostate-specific membrane antigen
      • Somatostatin receptors (Dotatate)
  • Gamma camera / SPECT-CT
    • Innervation (MIBG)
    • Bone metabolism / skeletal scintigraphy (MDP)
    • White blood cell scintigraphy
    • Somatostatin receptor scintigraphy
    • Sentinel lymph node scintigraphy
  • Other examination areas
    • Gamma camera / SPECT-CT
      • Testicular perfusion
      • Thyroid function
      • Nasolacrimal duct function 

Curriculum vitae

  • 04.1999 Habilitation, Department of Nuclear Medicine, University Hospital Münster
  • 07.1994 – 10.1995 Research Fellow, MRC Cyclotron Unit, Imperial College School of Medicine, London, UK
  • 06.1995 Doctoral Degree, Dr. med., Department of Nuclear Medicine, University Hospital Münster
  • 10.1987 – 06.1994 Study of Medicine, University of Münster
  • Since 12.2008, Full Professor of Nuclear Medicine, Director of the European Institute for Molecular Imaging (EIMI) and since 08/2013, Director of the Department of Nuclear Medicine, University Hospital Münster
  • Since 07.2007, Chairman of the European Institute for Molecular Imaging (EIMI), University of Münster
  • 09.1999 – 06.2007 C3 Professor (tenure track) of Experimental Nuclear Medicine, University of Münster

Awards

  • 09.2011 Poster Award of the German Society for Nephrology – German Society for Nephrology
  • 10.2004 Tyco Healthcare Advancement Award – German Society for Nuclear Medicine e.V.
  • 2004 Young Investigator Award – International Conference on Nuclear Cardiology (ICNC), Florence, Italy 

Social Activities

  • Since 2010, Chairman of the German Universities Nuclear Medicine National Committee
  • Since 2003, Chairman of the Cardiovascular Committee 
  • Member of the Society of Nuclear Medicine (SNM)  
  • Member of the European Society of Molecular Imaging (ESMI)  
  • Member of the German Cardiac Society (DGK) 
  • Member of the German Radiologist Association (DRG) 
  • Member of the German Society for Nuclear Medicine (DGN)

Research Focuses

  • Multimodal molecular imaging
  • Development of targeted imaging probes for molecular imaging of cardiovascular inflammation
  • Apoptosis and automatic innervation
  • Small animal imaging
  • Phenotyping of transgenic mouse models
  • Clinical multimodal cardiovascular research
  • Hybrid imaging

Department of Nuclear Medicine.
University Hospital Muenster:

Request more information now.
We will be happy to answer all your questions.



Need help?

Need Help?

Thank you!

We received your treatment application in the best Europe clinics. Our manager will contact you within the next 24 hours.